Financial Services and Markets Act 2000

Securitas has completed the acquisition of Stanley Security

Retrieved on: 
Friday, July 22, 2022
Group, Acquisition, Time, United Kingdom, Securitas AB, Stanley Black & Decker, CEO, Relevance (Person of Interest), Person, Solution, Compliance, Securities Act of 1933, Financial services, Risk management, Income, Safety, SEK, Prospectus, Finance, Electronic, Review, Company, Security (finance), MUSD, Guard, Growth, CEST, Financial Services and Markets Act 2000, Order, Cryptocurrency, EEA, Securitas

STOCKHOLM, July 22, 2022 /PRNewswire/ --The acquisition of Stanley Security is now completed and is consolidated into Securitas as of July 22, 2022.

Key Points: 
  • STOCKHOLM, July 22, 2022 /PRNewswire/ --The acquisition of Stanley Security is now completed and is consolidated into Securitas as of July 22, 2022.
  • On December 8, 2021, Securitas announced it had signed an agreement to acquire the Electronic Security Solutions business from Stanley Black & Decker Inc. ("Stanley Security") for a purchase price of MUSD 3200 on a debt and cash free basis.
  • "This transformational acquisition makes us a strong provider of tech-enabled security solutions and a leading partner to our clients on a global scale.
  • We are extremely pleased that the acquisition now is formally completed, and I want to welcome all of Stanley Security's clients and employees into the Securitas Group," says Magnus Ahlqvist, President and CEO of Securitas.

Thornburg Investment Management Obtains QDLP License in China

Retrieved on: 
Thursday, July 21, 2022
Association, Sale, Time, Investment, Corporation, Data, Thornburg Investment Management, Inc., Insurance, Industry, U.S. Securities and Exchange Commission, The Act, UK, FCA, Solution, Person, Judgement, Securities and Futures Commission, Risk, Risk management, SFC, TIM, Asa, UCITS, Company, Security (finance), Accounting, Institution, Communication, Mainland, Financial Services and Markets Act 2000, Financial services, Financial adviser, Bank, Limited

SHANGHAI, July 21, 2022 /PRNewswire/ -- Thornburg Investment Management ("Thornburg") today announced that its wholly foreign-owned enterprise, Thornburg Investment Management (Shanghai) Limited, has successfully filed for registration and has been granted a Qualified Domestic Limited Partnership ("QDLP") license from the China Asset Management Association.

Key Points: 
  • SHANGHAI, July 21, 2022 /PRNewswire/ -- Thornburg Investment Management ("Thornburg") today announced that its wholly foreign-owned enterprise, Thornburg Investment Management (Shanghai) Limited, has successfully filed for registration and has been granted a Qualified Domestic Limited Partnership ("QDLP") license from the China Asset Management Association.
  • "In our 40th anniversary year, the approval of the QDLP license marks an important milestone for Thornburg in its international expansion," said Thornburg President & CEO Jason Brady.
  • Thornburg Investment Management (Shanghai) Limited has assembled a dedicated team in Shanghai with deep expertise in business development and operations to serve the QDLP business.
  • For Hong Kong: This article is issued by Thornburg Investment Management (Asia)Limited ("Company"), a wholly-owned subsidiary of Thornburg Investment Management.Inc.

Charwood Energy: Success of Charwood Energy’s Initial Public Offering on Euronext Growth® Paris

Retrieved on: 
Friday, July 8, 2022
European Parliament, Diffusion, European Economic Area, Sokanu Interests, Personality, and Preferences Inventory, EBITDA, Sale, Company, Industry, AMF, Council, Prospectus, Order, United Kingdom, Risk, Person, Urban economics, Environment, Financial Services and Markets Act 2000, European, Group, Financial services, Finance, Solution, Heat, Biomass, Property management, Medical device, Security (finance), EU, Regulation

This information is based on data, assumptions and estimates considered as reasonable by Charwood Energy.

Key Points: 
  • This information is based on data, assumptions and estimates considered as reasonable by Charwood Energy.
  • This press release does not constitute or should not be considered as a public offering, an offer to subscribe companys securities or a public solicitation in preparation for a public offering of Charwood Energys securities.
  • This document does not constitute an offer to sell Charwood Energys securities in the United States of America.
  • Charwood Energy does not intend to register an offer or any public offering of securities, in the United States of America.

DGAP-News: TAG Immobilien AG resolves on €200m fully underwritten capital increase with subscription rights to refinance the bridge facility in relation to the acquisition of ROBYG S.A.

Retrieved on: 
Friday, July 8, 2022
Review, Joint Global Change Research Institute, Acquisition, European Parliament, European Economic Area, Securities Act of 1933, Offering, Article, Judgement of the German Federal Court of Justice on Google's autocomplete function, Physikalisch-Technische Bundesanstalt, Sale, Company, U.S. Securities and Exchange Commission, European Union (Withdrawal) Act 2018, Prospectus, Council, United Kingdom, Contract, Person, Investment, Urban economics, Communication, European, Financial Services and Markets Act 2000, Federal Financial Supervisory Authority, News, Relevance (Person of Interest), Financial services, Finance, DGAP, Knowledge, Forward-looking statement, Security (finance), EU, Regulation

This release constitutes neither an offer to sell nor a solicitation to buy securities of the Company.

Key Points: 
  • This release constitutes neither an offer to sell nor a solicitation to buy securities of the Company.
  • An investment decision regarding the securities of the Company should only be made on the basis of such securities prospectus.
  • This release is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons.
  • 08.07.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.

21Shares Announces Crypto Winter Suite

Retrieved on: 
Wednesday, June 29, 2022
Securities Act of 1933, AG, Advertising, Company, Multimedia, Issuer, Prospectus, SIX Swiss Exchange, Person, Communication, Financial Services and Markets Act 2000, Financial services, FSMA, Finance, ETP, EEA, SFSA, Cryptocurrency, Order, EU

ZURICH, June 29, 2022 /PRNewswire/ -- 21Shares AG ("21Shares"), the world's largest issuer of cryptocurrency exchange traded products (ETPs), today announced its Crypto Winter Suite – a set of products designed to help investors weather the bear market. The first product introduced in the suite is the 21Shares Bitcoin Core ETP (CBTC), which launched today on SIX Swiss Exchange.

Key Points: 
  • 21Shares takes innovation to the next level with the largest suite of cryptocurrency exchange-traded products (ETPs) in the world.
  • 21Shares aims to provide all investors with an easy, secure, and regulated way to buy, sell, and short cryptocurrency through existing bank and brokerage accounts.
  • 21Shares is a Swiss company registered in Zug, Switzerland with offices in Zurich and New York City.
  • This document is not an offer to sell or a solicitation of an offer to buy or subscribe for securities of 21Shares AG.

DGAP-News: Metalcorp Group successfully increases its secured 8.5% bond 2021/2026 by EUR 50 million

Retrieved on: 
Wednesday, June 15, 2022
DGAP, Finance, Order, Publication, Financial Services and Markets Act 2000, Person, Note, Prospectus, News, Financial services, Issuer, Securities Act of 1933, District, United Kingdom, Sale, EEA, Security (finance), EU

This publication is neither an offer to sell nor an offer to buy or subscribe for securities in the United States of America.

Key Points: 
  • This publication is neither an offer to sell nor an offer to buy or subscribe for securities in the United States of America.
  • Metalcorp Group S.A. did not make an offer of securities to the public.
  • 15.06.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
  • The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million

Retrieved on: 
Thursday, June 9, 2022
Cardiology, Company, US, Prejudice, Securities Act of 1933, Directive 2014/65/EU, Forward-looking statement, II, Nasdaq, Investment, European Union (Withdrawal) Act 2018, Person, Review, Prospectus, Finance, Special-purpose acquisition company, Neurovascular bundle, Financial Services and Markets Act 2000, Communication, Financial services, Crime, Testicular self-examination, Patient safety, Intention, Disclosure, Financial adviser, Cryptocurrency, Public relations, Medical device, Regulation, EU, EEA

STOCKHOLM, June 9, 2022 /PRNewswire/ -- Mentice AB ("Mentice" or the "Company") hereby announces intention to carry out a directed new issue of shares of approximately SEK 60 million directed to Swedish and international institutional investors (the "Directed New Share Issue"). The Directed New Share Issue will be carried out to, among other things, finance the acquisition of all assets relating to the software solution Ankyras from the Spanish company Galgo Medical S.L. (the "Acquisition") which the Company announced today in a separate press release. Mentice has engaged Pareto Securities AB ("Pareto Securities") as Sole Manager and Bookrunner to investigate the conditions for the Directed New Share Issue through an accelerated bookbuilding procedure.

Key Points: 
  • Mentice solutions are scientifically validated and are specifically developed for specialists in the healthcare sector and for the medical technology industry.
  • This information is such that Mentice AB is obliged to disclose pursuant to the EU Market Abuse Regulation.
  • This press release does not constitute a recommendation for any investors' decisions regarding the Directed New Share Issue.
  • This disclosure contains information that Mentice AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014).

Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million

Retrieved on: 
Thursday, June 9, 2022
Cardiology, Company, US, Prejudice, Securities Act of 1933, Directive 2014/65/EU, Forward-looking statement, II, Nasdaq, Investment, European Union (Withdrawal) Act 2018, Person, Review, Prospectus, Finance, Special-purpose acquisition company, Neurovascular bundle, Financial Services and Markets Act 2000, Communication, Financial services, Crime, Testicular self-examination, Patient safety, Intention, Disclosure, Financial adviser, Cryptocurrency, Public relations, Medical device, Regulation, EU, EEA

STOCKHOLM, June 9, 2022 /PRNewswire/ -- Mentice AB ("Mentice" or the "Company") hereby announces intention to carry out a directed new issue of shares of approximately SEK 60 million directed to Swedish and international institutional investors (the "Directed New Share Issue"). The Directed New Share Issue will be carried out to, among other things, finance the acquisition of all assets relating to the software solution Ankyras from the Spanish company Galgo Medical S.L. (the "Acquisition") which the Company announced today in a separate press release. Mentice has engaged Pareto Securities AB ("Pareto Securities") as Sole Manager and Bookrunner to investigate the conditions for the Directed New Share Issue through an accelerated bookbuilding procedure.

Key Points: 
  • Mentice solutions are scientifically validated and are specifically developed for specialists in the healthcare sector and for the medical technology industry.
  • This information is such that Mentice AB is obliged to disclose pursuant to the EU Market Abuse Regulation.
  • This press release does not constitute a recommendation for any investors' decisions regarding the Directed New Share Issue.
  • This disclosure contains information that Mentice AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014).

SES Successfully Prices EUR 750 million Eurobond

Retrieved on: 
Tuesday, June 7, 2022
Finance, Satellite, Professional Services, Technology, Telecommunications, United Kingdom, Parliament, European Economic Area, Prospectus, Prejudice, Directive 2014/65/EU, Securities Act of 1933, II, Urban economics, SESG, Solution, Telecommunication, Sale, SES, Finance, State, Ticker, Atmosphere, Financial Services and Markets Act 2000, Financial services, Person, Council, Security (finance), Medical device, Medium Earth orbit

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world.

Key Points: 
  • SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world.
  • As the leader in global content connectivity solutions, SES operates the worlds only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system.
  • SESs video network carries over 8,400 channels and has an unparalleled reach of 366 million households, delivering managed media services for both linear and non-linear content.
  • Any person who is not a relevant person should not act or rely on this document or any of its contents.

Zealand Pharma completes registration of capital increase

Retrieved on: 
Friday, June 3, 2022
ACT, Mission statement, AS, NOT, FINANCIAL, Failure, Private, BY, Sale, AstraZeneca, Finance, COVID-19, Financial Services and Markets Act 2000, ANY, Association, Advertising, Intellectual property, AFRICA, Order, Income, Structured Product Labeling, European Union (Withdrawal) Act 2018, EEA, DKK, United Kingdom, THE, Boehringer Ingelheim, FOR, OF, Patient, Nasdaq Copenhagen, Private Securities Litigation Reform Act, Research, Nasdaq, ISIN, OR, Prospectus, Zealand Pharma, District, Financial services, Private placement, Person, Security (finance), Financial adviser, Life insurance, Cryptocurrency, Property management, EU

3/2022, Zealand Pharma A/S ("Zealand") announces that it has today, as part of completion of a directed issue and private placement (the "Private Placement"), registered with the Danish Business Authority, the capital increase of DKK 2,892,368, divided into 2,892,368 ordinary shares (the "New Shares").

Key Points: 
  • 3/2022, Zealand Pharma A/S ("Zealand") announces that it has today, as part of completion of a directed issue and private placement (the "Private Placement"), registered with the Danish Business Authority, the capital increase of DKK 2,892,368, divided into 2,892,368 ordinary shares (the "New Shares").
  • The amendments to Zealand's articles of association required by the capital increase have been registered today with the Danish Business Authority.
  • Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, development, and commercialization of peptide-based medicines.
  • All such forward-looking statements speak only as of the date of this press release and are based on information available to Zealand Pharma as of the date of this release.